The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound

Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

[search][options]

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Rachel Schiff

Department of Medicine

Baylor College of Medicine

Houston

Texas 77030

USA

[email]@breastcenter.tmc.edu

Name/email consistency: high

[Claim this account]

Affiliation

Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA. 2003 - 2006

References

Can biomarkers direct the optimal use of aromatase inhibitors versus selective estrogen receptor modulators?. Schiff, R., Lee, A.V. Nature Clinical Practice. Oncology (2006) [Pubmed]
Endocrinology and hormone therapy in breast cancer: new insight into estrogen receptor-alpha function and its implication for endocrine therapy resistance in breast cancer. Schiff, R., Osborne, C.K. Breast Cancer Res. (2005) [Pubmed]
Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators. Schiff, R., Massarweh, S.A., Shou, J., Bharwani, L., Arpino, G., Rimawi, M., Osborne, C.K. Cancer Chemother. Pharmacol. (2005) [Pubmed]
Cross-talk between estrogen receptor and growth factor pathways as a molecular target for overcoming endocrine resistance. Schiff, R., Massarweh, S.A., Shou, J., Bharwani, L., Mohsin, S.K., Osborne, C.K. Clin. Cancer Res. (2004) [Pubmed]
Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response. Schiff, R., Massarweh, S., Shou, J., Osborne, C.K. Clin. Cancer Res. (2003) [Pubmed]
Advances in breast cancer treatment and prevention: preclinical studies on aromatase inhibitors and new selective estrogen receptor modulators (SERMs). Schiff, R., Chamness, G.C., Brown, P.H. Breast Cancer Res. (2003) [Pubmed]